An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.

Saved in:
Bibliographic Details
Title: An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.
Authors: Shannon AB; Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. Adrienne.shannon@pennmedicine.upenn.edu., Straker RJ 3rd; Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Carr MJ; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Sun J; Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Landa K; Division of Surgical Oncology, Department of Surgery, Duke University Medical Center, Durham, NC, USA., Baecher K; Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA., Lynch K; Division of Breast and Melanoma Surgery, Department of Surgery, University of Virginia, Charlottesville, VA, USA., Bartels HG; Division of Head and Neck Surgical Oncology, Department of Otolaryngology, University of Virginia, Charlottesville, VA, USA., Panchaud R; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA.; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA., Keele LJ; Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Lowe MC; Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA., Slingluff CL; Division of Breast and Melanoma Surgery, Department of Surgery, University of Virginia, Charlottesville, VA, USA., Jameson MJ; Division of Head and Neck Surgical Oncology, Department of Otolaryngology, University of Virginia, Charlottesville, VA, USA., Tsai KY; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA.; Department of Pathology, Moffitt Cancer Center, Tampa, FL, USA., Faries MB; Division of Surgical Oncology, Cedars-Sinai Medical Center, The Angeles Clinic and Research Institute, Los Angeles, CA, USA., Beasley GM; Division of Surgical Oncology, Department of Surgery, Duke University Medical Center, Durham, NC, USA., Sondak VK; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Karakousis GC; Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Zager JS; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.; Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA., Miura JT; Division of Endocrine and Oncologic Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Source: Annals of surgical oncology [Ann Surg Oncol] 2022 Oct; Vol. 29 (11), pp. 7033-7044. Date of Electronic Publication: 2022 Jul 22.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1534-4681
DOI:10.1245/s10434-022-12201-z